Cargando…

Correction: Faria, A.V.S. et al., Targeting Tyrosine Phosphatases by 3-Bromopyruvate Overcomes Hyperactivation of Platelets from Gastrointestinal Cancer Patients. J. Clin. Med. 2019, 8, 936

Detalles Bibliográficos
Autores principales: Faria, Alessandra V. S., Andrade, Sheila S., Reijm, Agnes N., Spaander, Manon C. W., de Maat, Moniek P. M., Peppelenbosch, Maikel P., Ferreira-Halder, Carmen V., Fuhler, Gwenny M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465274/
https://www.ncbi.nlm.nih.gov/pubmed/32823601
http://dx.doi.org/10.3390/jcm9082625
_version_ 1783577552280879104
author Faria, Alessandra V. S.
Andrade, Sheila S.
Reijm, Agnes N.
Spaander, Manon C. W.
de Maat, Moniek P. M.
Peppelenbosch, Maikel P.
Ferreira-Halder, Carmen V.
Fuhler, Gwenny M.
author_facet Faria, Alessandra V. S.
Andrade, Sheila S.
Reijm, Agnes N.
Spaander, Manon C. W.
de Maat, Moniek P. M.
Peppelenbosch, Maikel P.
Ferreira-Halder, Carmen V.
Fuhler, Gwenny M.
author_sort Faria, Alessandra V. S.
collection PubMed
description
format Online
Article
Text
id pubmed-7465274
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-74652742020-09-04 Correction: Faria, A.V.S. et al., Targeting Tyrosine Phosphatases by 3-Bromopyruvate Overcomes Hyperactivation of Platelets from Gastrointestinal Cancer Patients. J. Clin. Med. 2019, 8, 936 Faria, Alessandra V. S. Andrade, Sheila S. Reijm, Agnes N. Spaander, Manon C. W. de Maat, Moniek P. M. Peppelenbosch, Maikel P. Ferreira-Halder, Carmen V. Fuhler, Gwenny M. J Clin Med Correction MDPI 2020-08-13 /pmc/articles/PMC7465274/ /pubmed/32823601 http://dx.doi.org/10.3390/jcm9082625 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Correction
Faria, Alessandra V. S.
Andrade, Sheila S.
Reijm, Agnes N.
Spaander, Manon C. W.
de Maat, Moniek P. M.
Peppelenbosch, Maikel P.
Ferreira-Halder, Carmen V.
Fuhler, Gwenny M.
Correction: Faria, A.V.S. et al., Targeting Tyrosine Phosphatases by 3-Bromopyruvate Overcomes Hyperactivation of Platelets from Gastrointestinal Cancer Patients. J. Clin. Med. 2019, 8, 936
title Correction: Faria, A.V.S. et al., Targeting Tyrosine Phosphatases by 3-Bromopyruvate Overcomes Hyperactivation of Platelets from Gastrointestinal Cancer Patients. J. Clin. Med. 2019, 8, 936
title_full Correction: Faria, A.V.S. et al., Targeting Tyrosine Phosphatases by 3-Bromopyruvate Overcomes Hyperactivation of Platelets from Gastrointestinal Cancer Patients. J. Clin. Med. 2019, 8, 936
title_fullStr Correction: Faria, A.V.S. et al., Targeting Tyrosine Phosphatases by 3-Bromopyruvate Overcomes Hyperactivation of Platelets from Gastrointestinal Cancer Patients. J. Clin. Med. 2019, 8, 936
title_full_unstemmed Correction: Faria, A.V.S. et al., Targeting Tyrosine Phosphatases by 3-Bromopyruvate Overcomes Hyperactivation of Platelets from Gastrointestinal Cancer Patients. J. Clin. Med. 2019, 8, 936
title_short Correction: Faria, A.V.S. et al., Targeting Tyrosine Phosphatases by 3-Bromopyruvate Overcomes Hyperactivation of Platelets from Gastrointestinal Cancer Patients. J. Clin. Med. 2019, 8, 936
title_sort correction: faria, a.v.s. et al., targeting tyrosine phosphatases by 3-bromopyruvate overcomes hyperactivation of platelets from gastrointestinal cancer patients. j. clin. med. 2019, 8, 936
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465274/
https://www.ncbi.nlm.nih.gov/pubmed/32823601
http://dx.doi.org/10.3390/jcm9082625
work_keys_str_mv AT fariaalessandravs correctionfariaavsetaltargetingtyrosinephosphatasesby3bromopyruvateovercomeshyperactivationofplateletsfromgastrointestinalcancerpatientsjclinmed20198936
AT andradesheilas correctionfariaavsetaltargetingtyrosinephosphatasesby3bromopyruvateovercomeshyperactivationofplateletsfromgastrointestinalcancerpatientsjclinmed20198936
AT reijmagnesn correctionfariaavsetaltargetingtyrosinephosphatasesby3bromopyruvateovercomeshyperactivationofplateletsfromgastrointestinalcancerpatientsjclinmed20198936
AT spaandermanoncw correctionfariaavsetaltargetingtyrosinephosphatasesby3bromopyruvateovercomeshyperactivationofplateletsfromgastrointestinalcancerpatientsjclinmed20198936
AT demaatmoniekpm correctionfariaavsetaltargetingtyrosinephosphatasesby3bromopyruvateovercomeshyperactivationofplateletsfromgastrointestinalcancerpatientsjclinmed20198936
AT peppelenboschmaikelp correctionfariaavsetaltargetingtyrosinephosphatasesby3bromopyruvateovercomeshyperactivationofplateletsfromgastrointestinalcancerpatientsjclinmed20198936
AT ferreirahaldercarmenv correctionfariaavsetaltargetingtyrosinephosphatasesby3bromopyruvateovercomeshyperactivationofplateletsfromgastrointestinalcancerpatientsjclinmed20198936
AT fuhlergwennym correctionfariaavsetaltargetingtyrosinephosphatasesby3bromopyruvateovercomeshyperactivationofplateletsfromgastrointestinalcancerpatientsjclinmed20198936